Brian le, DO
Pain Medicine · Las Vegas, NVNPI 1942341854
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Nevro Corp. at 29.8% of the total.
Across 128 payments — averaging $32.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Abbott$949
- Medtronic$552
- Globus Medical$315
- Forte Bio-pharma LLC$252
- Nalu Medical, Inc.$129
- plus $758 from 22 others
What the payments were for
- Travel & lodging$1273%
- Food & beverage$4,08197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 13 | $1,252 |
| Abbott | 27 | $949 |
| Medtronic(2 entities) | 25 | $552 |
| Globus Medical | 11 | $315 |
| Forte Bio-pharma LLC | 11 | $252 |
| Nalu Medical, Inc. | 3 | $129 |
| Lundbeck LLC | 4 | $89 |
| Si-bone, Inc. | 5 | $88 |
| AbbVie | 6 | $81 |
| Biotronik NRO, Inc. | 2 | $81 |
| Vertos Medical, Inc. | 2 | $66 |
| Boston Scientific | 3 | $56 |
| Johnson & Johnson | 1 | $34 |
| Merz North America, Inc. | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Appliedvr Inc | 1 | $22 |
| Amgen | 1 | $19 |
| Pfizer | 1 | $17 |
| Abiomed | 1 | $17 |
| Stratus Medical, LLC | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Painteq LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Protega Pharmaceutials Inc | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $15 |
| Curonix LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$749
- Senza$368
- PENTA$272
- INTELLIS$147
- Penta SCS Leads$146
How this compares
$4,208 in reported general payments places this provider in the 60th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $539 |
| Celecoxib | 21 | $298 |
| Duloxetine Hcl | 13 | $188 |
| Tizanidine Hcl | 22 | $124 |
| Gabapentin | 12 | $117 |
| Meloxicam | 21 | $46 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.